Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schölkens

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The American Journal of Cardiology|April 24, 1987
Ramipril: review of pharmacologyR A Becker, B Schölkens
Arzneimittel-Forschung|January 1, 1980
[On the pharmacology of the beta-receptor blocker penbutolol (author's transl)]J Kaiser, G Härtfelder, E Lindner, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitorsP Gohlke, H Urbach, B Schölkens, et al.
American Journal of Hypertension|April 1, 1989
Cardiac renin-angiotensin systemW Linz, B Schölkens, K Lindpaintner, et al.
European Journal of Pharmacology|April 9, 1981
Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive ratsT Unger, I Kaufmann-Bühler, B Schölkens, et al.
Basic Research in Cardiology|May 1, 1981
Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog heartsJ Scholtholt, H Birringer, V B Fiedler, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288P Gohlke, B Schölkens, R Henning, et al.
Prostaglandins|July 1, 1980
Antihypertensive activity of 16, 16-dimethyl-oxa-alkyl-prostaglandins of the PGA2, PGE2 and trans-delta 2-11-deoxy-PGE1 series: structure-activity relationshipsG Beck, W Bartmann, U Lerch, et al.
Prostaglandins|February 1, 1979
Luteolytic prostaglandins. Synthesis and biological activityW Bartmann, G Beck, U Lerch, et al.
Arzneimittel-Forschung|January 1, 1983
Vascular effects of piretanide. Studies on extrarenal action in several animal modelsE Klaus, H G Alpermann, G Caspritz, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|April 24, 1987
Ramipril: review of pharmacologyR A Becker, B Schölkens
Arzneimittel-Forschung|January 1, 1980
[On the pharmacology of the beta-receptor blocker penbutolol (author's transl)]J Kaiser, G Härtfelder, E Lindner, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitorsP Gohlke, H Urbach, B Schölkens, et al.
American Journal of Hypertension|April 1, 1989
Cardiac renin-angiotensin systemW Linz, B Schölkens, K Lindpaintner, et al.
European Journal of Pharmacology|April 9, 1981
Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive ratsT Unger, I Kaufmann-Bühler, B Schölkens, et al.
Basic Research in Cardiology|May 1, 1981
Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog heartsJ Scholtholt, H Birringer, V B Fiedler, et al.
Journal of Cardiovascular Pharmacology|January 1, 1989
Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288P Gohlke, B Schölkens, R Henning, et al.
Prostaglandins|July 1, 1980
Antihypertensive activity of 16, 16-dimethyl-oxa-alkyl-prostaglandins of the PGA2, PGE2 and trans-delta 2-11-deoxy-PGE1 series: structure-activity relationshipsG Beck, W Bartmann, U Lerch, et al.
Prostaglandins|February 1, 1979
Luteolytic prostaglandins. Synthesis and biological activityW Bartmann, G Beck, U Lerch, et al.
Arzneimittel-Forschung|January 1, 1983
Vascular effects of piretanide. Studies on extrarenal action in several animal modelsE Klaus, H G Alpermann, G Caspritz, et al.
Pageof 2